Viewing Study NCT05312632


Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2025-12-30 @ 7:09 PM
Study NCT ID: NCT05312632
Status: COMPLETED
Last Update Posted: 2024-09-23
First Post: 2022-03-28
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Efficacy and Safety of Safinamide Mesilate as Add-on Therapy to Levodopa in Parkinson's Disease Participants With Motor Fluctuation in South Korea
Sponsor: Eisai Korea Inc.
Organization: